Webinar-Postmarket Management of Cybersecurity in Medical Devices-Final Guidance-January 12 2017
U.S. Food and Drug Administration. (2018). Webinar-Postmarket Management of Cybersecurity in Medical Devices-Final Guidance-January 12, 2017.
This webinar sponsored by the U.S. Food and Drug Administration (FDA): clarified recommendations for managing postmarket cybersecurity vulnerabilities; emphasized the importance of monitoring, identifying, and addressing cybersecurity vulnerabilities and attacks on a continual basis; highlighted the importance of establishing a risk-based framework for assessing when changes to medical devices for cybersecurity vulnerabilities require reporting to the FDA; and outlined circumstances in which the FDA does not intend to enforce reporting requirements under 21 CFR, part 806.
Login to rate, favorite, and comments on the article
You must Login to add a comment
- This item doesn't have any comments